Metastatic prostate cancer with elevated serum levels of CEA and CA19-9

Guang Dar Juang, Yi-Sheng Huang, Yuan Hung Wang

研究成果: 雜誌貢獻文章同行評審

4 引文 斯高帕斯(Scopus)

摘要

Prostate-specific antigen (PSA) is well known as a specific tumor marker for prostate cancer, but carcinoembryonic antigen (CEA)- and carbohydrate antigen 19-9 (CA19-9)-elevating adenocarcinomas originating in the prostate gland are rare. We report a case of metastatic adenocarcinoma of the prostate gland with a high serum level of CEA and CA19-9 in a 78-year-old man in whom prostate cancer (T3N1M1) had been diagnosed 2 years ago and who was treated with androgen deprivation therapy. He visited the emergency department because of a loss of appetite and abdominal pain. The serum CEA and CA19-9 levels were increased to 218.9. ng/mL (normal,
原文英語
頁(從 - 到)28-30
頁數3
期刊Urological Science
25
發行號1
DOIs
出版狀態已發佈 - 2014

ASJC Scopus subject areas

  • 泌尿科學

指紋

深入研究「Metastatic prostate cancer with elevated serum levels of CEA and CA19-9」主題。共同形成了獨特的指紋。

引用此